利妥昔单抗-CHOP联合化疗成功治疗血管内B细胞淋巴瘤复发 - Suppr

Suppr

超能文献

Successful treatment of relapse of an intravascular B-cell lymphoma with rituximab-CHOP polychemotherapy.

作者信息

Takács István, Eros N, Bene I, Bozsó F, Tordai L, Károlyi Z, Radványi G, Matolcsy A

出版信息

Ann Hematol. 2004 Sep;83(9):608-10. doi: 10.1007/s00277-004-0897-0. Epub 2004 Jun 16.

DOI:10.1007/s00277-004-0897-0

PMID:15205915

Abstract

摘要

相似文献

Successful treatment of relapse of an intravascular B-cell lymphoma with rituximab-CHOP polychemotherapy.

Ann Hematol. 2004 Sep;83(9):608-10. doi: 10.1007/s00277-004-0897-0. Epub 2004 Jun 16.

CHOP plus rituximab--balancing facts and opinion.

N Engl J Med. 2002 Jan 24;346(4):280-2. doi: 10.1056/NEJM200201243460411.

[Clinical analysis of rituximab combined with chemotherapy in treating aggressive B-cell non-Hodgkin's lymphoma].

Ai Zheng. 2004 Dec;23(12):1681-6.

Higher fungal infection rate in elderly patients (more than 80 years old) suffering from diffuse large B cell lymphoma and treated with rituximab plus CHOP.

Ann Hematol. 2007 Feb;86(2):95-100. doi: 10.1007/s00277-006-0191-4. Epub 2006 Oct 10.

Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).

J Clin Oncol. 2005 Mar 20;23(9):1984-92. doi: 10.1200/JCO.2005.08.133. Epub 2005 Jan 24.

A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma.

Cancer. 2006 Dec 15;107(12):2826-32. doi: 10.1002/cncr.22342.

Pharmacokinetics of rituximab associated with CHOP chemotherapy in B-cell non-Hodgkin lymphoma.

Fundam Clin Pharmacol. 2009 Oct;23(5):601-8. doi: 10.1111/j.1472-8206.2009.00714.x. Epub 2009 Jul 29.

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte.

J Clin Oncol. 2005 Jun 20;23(18):4117-26. doi: 10.1200/JCO.2005.09.131. Epub 2005 May 2.

Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone plus bortezomib in patients with B-cell lymphoma: a randomized phase 2 trial from the French Adult Lymphoma Study Group (GELA).

Cancer. 2009 Oct 1;115(19):4540-6. doi: 10.1002/cncr.24518.

[How to improve the efficacy of R-CHOP for indolent B-cell lymphoma?].

Rinsho Ketsueki. 2012 Jun;53(6):609-17.

引用本文的文献

Generalized Telangiectasia as a Hallmark of Intravascular Lymphoma: A Case Report and Literature Review.

Healthcare (Basel). 2024 Jul 22;12(14):1455. doi: 10.3390/healthcare12141455.

A bispecific antibody directly induces lymphoma cell death by simultaneously targeting CD20 and HLA-DR.

J Cancer Res Clin Oncol. 2015 Nov;141(11):1899-907. doi: 10.1007/s00432-015-1949-7. Epub 2015 Mar 14.

Intravascular large B cell lymphoma: proposed of the strategy for early diagnosis and treatment of patients with rapid deteriorating condition.

Int J Hematol. 2009 Jun;89(5):600-10. doi: 10.1007/s12185-009-0304-7. Epub 2009 Apr 14.

Chemotherapy-resistant intravascular lymphoma accompanied by ADAMTS13 inhibitor successfully treated with rituximab.

Int J Hematol. 2008 Oct;88(3):345-347. doi: 10.1007/s12185-008-0143-y. Epub 2008 Aug 19.

[Intravascular lymphoma: two case reports demonstrating the heterogeneity of the disease].

Hautarzt. 2009 Feb;60(2):131-6. doi: 10.1007/s00105-008-1583-2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验